You're reading the free version. Trader adds the live tape and alerts.
Start tracking
LGND Exercise Disclosure
Sabba Stephen L · SEC Form 4 · Filed Jun 18, 2026
Exercise
Calculated transaction value
$0
Sabba Stephen L Director
LGND
Transaction date
Jun 16, 2026
Public filing date
Jun 18, 2026
Filing lag
Filed 2 days later
LGND daily price context
Close on/before transaction
$255.25
Jun 16, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Non-Qualified Stock Option (right to buy) on Common Stock
- Quantity / price
- 2,145 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001104659-26-075456
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$686.68K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Ligand Pharmaceuticals Inc LGND | Exercise | Jun 16, 2026 | $141.85K |
| Ligand Pharmaceuticals Inc LGND | Sale | Jun 16, 2026 | $544.83K |
| Ligand Pharmaceuticals Inc LGND Current | Exercise | Jun 16, 2026 | $0 |